These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 18645679

  • 21. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y, Chatterjee SJ, Brands FH, Shi SR, Pootrakul L, Taylor CR, Datar R, Cote RJ.
    BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
    [Abstract] [Full Text] [Related]

  • 22. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B, Zhang H, Wang J, Chen WZ, Li SH, Shi QG, Liang RX, Xie BX, Wu RQ, Qian XL, Yu L, Li QM, Huang CF, Zhou JG.
    Prostate; 2009 Aug 01; 69(11):1176-87. PubMed ID: 19415690
    [Abstract] [Full Text] [Related]

  • 23. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ, Peng Y, Buckley MT, Wei J, Chen F, Liebes L, Gerald WL, Pincus MR, Osman I, Lee P.
    Oncogene; 2008 May 15; 27(22):3201-10. PubMed ID: 18193092
    [Abstract] [Full Text] [Related]

  • 24. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM, Yu J, Khoury T, Chadha KS, Iyer RV, Foster J, Kuvshinoff BW, Gibbs JF, Geradts J, Black JD, Brattain MG.
    J Gastroenterol Hepatol; 2006 Nov 15; 21(11):1744-51. PubMed ID: 16984600
    [Abstract] [Full Text] [Related]

  • 25. Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
    Hobisch A, Fiechtl M, Sandahl-Sorensen B, Godoy-Tundidor S, Artner-Dworzak E, Ramoner R, Bartsch G, Culig Z.
    Prostate; 2004 Jun 01; 59(4):401-8. PubMed ID: 15065088
    [Abstract] [Full Text] [Related]

  • 26. Epidermal growth factor receptor transactivation is required for proteinase-activated receptor-2-induced COX-2 expression in intestinal epithelial cells.
    Hirota CL, Moreau F, Iablokov V, Dicay M, Renaux B, Hollenberg MD, MacNaughton WK.
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul 01; 303(1):G111-9. PubMed ID: 22517768
    [Abstract] [Full Text] [Related]

  • 27. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
    Ferrandina G, Ranelletti FO, Lauriola L, Fanfani F, Legge F, Mottolese M, Nicotra MR, Natali PG, Zakut VH, Scambia G.
    Gynecol Oncol; 2002 May 01; 85(2):305-10. PubMed ID: 11972392
    [Abstract] [Full Text] [Related]

  • 28. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.
    Pignon JC, Koopmansch B, Nolens G, Delacroix L, Waltregny D, Winkler R.
    Cancer Res; 2009 Apr 01; 69(7):2941-9. PubMed ID: 19318561
    [Abstract] [Full Text] [Related]

  • 29. Activation of the epidermal growth factor receptor in optic nerve astrocytes leads to early and transient induction of cyclooxygenase-2.
    Zhang X, Neufeld AH.
    Invest Ophthalmol Vis Sci; 2005 Jun 01; 46(6):2035-41. PubMed ID: 15914620
    [Abstract] [Full Text] [Related]

  • 30. COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
    Foster J, Black J, LeVea C, Khoury T, Kuvshinoff B, Javle M, Gibbs JF.
    Ann Surg Oncol; 2007 Feb 01; 14(2):752-8. PubMed ID: 17146741
    [Abstract] [Full Text] [Related]

  • 31. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
    Volante M, Saviozzi S, Rapa I, Ceppi P, Cappia S, Calogero R, Novello S, Borasio P, Papotti M, Scagliotti GV.
    Cancer; 2007 Sep 15; 110(6):1321-8. PubMed ID: 17647268
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.
    Lev-Ari S, Starr A, Vexler A, Karaush V, Loew V, Greif J, Fenig E, Aderka D, Ben-Yosef R.
    Anticancer Res; 2006 Sep 15; 26(6B):4423-30. PubMed ID: 17201164
    [Abstract] [Full Text] [Related]

  • 33. Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines.
    Bonaccorsi L, Nosi D, Muratori M, Formigli L, Forti G, Baldi E.
    J Mol Endocrinol; 2007 Feb 15; 38(1-2):51-66. PubMed ID: 17242169
    [Abstract] [Full Text] [Related]

  • 34. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
    König JE, Senge T, Allhoff EP, König W.
    Prostate; 2004 Feb 01; 58(2):121-9. PubMed ID: 14716737
    [Abstract] [Full Text] [Related]

  • 35. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO.
    Cancer; 2007 May 15; 109(10):2016-24. PubMed ID: 17394193
    [Abstract] [Full Text] [Related]

  • 36. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
    Paliouras M, Diamandis EP.
    Biol Chem; 2008 Jun 15; 389(6):773-80. PubMed ID: 18627304
    [Abstract] [Full Text] [Related]

  • 37. Helicobacter pylori enhances cyclooxygenase 2 expression via p38MAPK/ATF-2 signaling pathway in MKN45 cells.
    Li Q, Liu N, Shen B, Zhou L, Wang Y, Wang Y, Sun J, Fan Z, Liu RH.
    Cancer Lett; 2009 Jun 08; 278(1):97-103. PubMed ID: 19201083
    [Abstract] [Full Text] [Related]

  • 38. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.
    Marks RA, Zhang S, Montironi R, McCarthy RP, MacLennan GT, Lopez-Beltran A, Jiang Z, Zhou H, Zheng S, Davidson DD, Baldridge LA, Cheng L.
    Prostate; 2008 Jun 15; 68(9):919-23. PubMed ID: 18409189
    [Abstract] [Full Text] [Related]

  • 39. [Literature-mining and bioinformatic analysis of androgen-independent prostate cancer-specific genes].
    Li TQ, Feng CQ, Zou YG, Shi R, Liang S, Mao XM.
    Zhonghua Nan Ke Xue; 2009 Dec 15; 15(12):1102-7. PubMed ID: 20180422
    [Abstract] [Full Text] [Related]

  • 40. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
    Oosterhoff JK, Grootegoed JA, Blok LJ.
    Endocr Relat Cancer; 2005 Mar 15; 12(1):135-48. PubMed ID: 15788645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.